Because BRM-741 and BRM-1321 can affect the expression of BRM and thus the activity of SWI/SNF, it is reasonable to suspect that these two polymorphisms may influence the risk or prognosis of human cancers. The gene discussed is SMARCA2; the disease is cancer.